encyclopedia of medical concepts
ψ 
ψ 
ψ 

Myasthenia Gravis, Neonatal

More information in Books or onNLM PubMed
Definition: A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48(1):50-4)      Other names Myasthenia Gravis, Antenatal; Transient Neonatal Myasthenia Gravis; Persistent Neonatal Myasthenia Gravis; Neonatal Myasthenia Gravis, Transient; Neonatal Myasthenia Gravis, Persistent; Myasthenia Gravis, Transient, Neonatal; Myasthenia Gravis, Persistent, Neonatal; Myasthenia Gravis, Neonatal, Transient; Myasthenia Gravis, Neonatal, Persistent; Neonatal Myasthenia Gravis; Antenatal Myasthenia Gravis

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy